Blog

Archive for the ‘biotech/medical’ category: Page 2465

Jan 9, 2017

Researchers reveal how cancer cells cope with genetic chaos

Posted by in categories: biotech/medical, genetics

Another difference between normal and abnormal cells — cancer cells can continue to grow despite damage to cell structures and changes in the number of chromosomes.


Scientists have uncovered how tumours are able to grow despite significant damage to the structure and number of their chromosomes — the storage units of DNA — according to two new studies published in Cancer Cell and Cancer Discovery today.

“We hope that understanding these mechanisms will allow us to limit drug resistance and improve the efficacy of cancer therapies.” - Professor Charles Swanton

Continue reading “Researchers reveal how cancer cells cope with genetic chaos” »

Jan 9, 2017

Scientists Have Found a Drug That Regenerates Teeth, and It Could Reduce the Need for Fillings

Posted by in categories: biotech/medical, materials

Researchers have identified a drug that can regenerate teeth from the inside out, possibly reducing the need for artificial fillings.

The drug was previously used in Alzheimer’s clinical trials, and it now appears to improve the tooth’s natural ability to heal itself. It works by activating stem cells inside the tooth’s pulp centre, prompting the damaged area to regenerate the hard dentin material that makes up the majority of a tooth.

“The simplicity of our approach makes it ideal as a clinical dental product for the natural treatment of large cavities, by providing both pulp protection and restoring dentine,” said lead author Paul Sharpe from King’s College London.

Continue reading “Scientists Have Found a Drug That Regenerates Teeth, and It Could Reduce the Need for Fillings” »

Jan 9, 2017

Calorie Restriction as a Means to Improve Surgical Outcomes

Posted by in categories: biotech/medical, food, health, life extension

More data for caloric restriction and health benefits.


The long-term response to calorie restriction has long been of interest to the aging research community, and particularly in the past few decades as the tools of biotechnology allowed for a more detailed analysis of the metabolic changes that accompany a reduced calorie intake. A restricted diet extends healthy life spans in near all species tested to date, though to a much greater extent in short-lived species than in long-lived species such as our own. Considerable effort is presently devoted to the development of drugs that can replicate some fraction of calorie restriction — more effort than is merited in my opinion, given that the optimal result for extension of human life span achieved via calorie restriction mimetics will be both hard to achieve safely and very limited in comparison to the gains possible through rejuvenation therapies after the SENS model. Repairing damage within the existing system should be expected to outdo attempts to change the system in order to slow the accumulation of damage, in both efficiency and size of result.

Not everyone is interested in the long term, however. The short term health benefits of calorie restriction appear quickly and are surprisingly similar in mice and humans, given that calorie restriction in mice results in significantly extended life and calorie restriction in humans does not. The beneficial adjustments to metabolism and organ function are for the most part larger and more reliable than similar gains presently achievable through forms of medicine. That is more a case of medical science having a long way to go yet than calorie restriction being wondrous, however. Still, the short term benefits are coming to the attention to wider audience within the research and medical community.

Continue reading “Calorie Restriction as a Means to Improve Surgical Outcomes” »

Jan 9, 2017

Don’t Thank Big Government for Medical Breakthroughs

Posted by in categories: biotech/medical, economics, government, life extension

Grassroots funding of fundamental science and private enterprize will lead the way in rejuvenation biotechnology not the traditional funding sources from Government which are shrinking every year.


It is important to understand that innovation and progress is unlikely to come from the Government and the traditional grant system which is shrinking every year. Rejuvenation biotechnology will likely be funded with a mix of fundraising for fundamental breakthrough technologies followed by private enterprize taking discoveries to market. This is why supporting science is critcial as relying on the Government to innovate and drive progress is unlikely to yield results anytime soon.

“Today, researchers compete for government grants at increasingly shorter intervals and with diminishing chances of success: Less than 1 in 5 grant applications succeeds. This inhibits risk taking.

Continue reading “Don’t Thank Big Government for Medical Breakthroughs” »

Jan 9, 2017

How CRISPR gene editing puts scientists in the driver’s seat of evolution

Posted by in categories: bioengineering, biotech/medical, evolution

CRISPR can help us end many diseases and guide evolution and is probably one of the most powerful tools we have recently added to our toolkit.


Imagine you could edit a mouse’s genes to be resistant to Lyme Disease. The mouse would breed and evolution would take its course, leading to the extinction of the disease. That’s the vision for scientists developing CRISPR, technology that allows scientists to rewrite the code of life. William Brangham talks to Michael Specter who wrote about CRISPR for The New Yorker.

Read more

Jan 9, 2017

Illumina Adds IBM Watson To DNA Test For Cancer Patients

Posted by in categories: biotech/medical, robotics/AI

Teaming up with IBM Watson’s artificial intelligence to help simplify genomics for cancer tests: http://bit.ly/2iVEn58

Read more

Jan 8, 2017

Anti-aging therapies targeting senescent cells: Facts and fiction

Posted by in categories: biotech/medical, life extension

It’s an exciting time to be an elderly mouse. Researchers believe that by removing senescent cells (cells with a persistent damage response), which naturally accumulate with age, senior rodents can regrow hair, run faster, and improve organ function. This strategy may bring us one step closer to the “fountain of youth,” but it’s important to be cautious and not hype, says researcher of aging Peter de Keizer of the Erasmus University Medical Center in the Netherlands. In an Opinion published December 29 in Trends in Molecule Medicine, he discusses the milestones the field still needs to hit before translation in humans is ready for discussion.

#aging #crowdfundthecure

https://www.sciencedaily.com/releases/2016/12/161229141835.htm

Continue reading “Anti-aging therapies targeting senescent cells: Facts and fiction” »

Jan 8, 2017

The Biocrystal- Holographic Properties Of DNA

Posted by in categories: biotech/medical, materials

Interesting position.


Anonymous by request.

The human energy field exists as an array of oscillating energy points that have a layered structure and a definite symmetry and these properties fulfill the definition of a normal crystal in material form” – Marc Vogel.

Continue reading “The Biocrystal- Holographic Properties Of DNA” »

Jan 8, 2017

Delayed Chemo Can Still Benefit in Lung Cancer

Posted by in category: biotech/medical

Interesting find.


Patient recovery may mean longer time to the treatment, but study suggests it can still have benefit.

Read more

Jan 8, 2017

Can Silicon Valley cure cancer? Napster founder Sean Parker says yes

Posted by in categories: biotech/medical, education, media & arts

No surprises here. We all have known that with tech in medical research and development would and will continue to solve many diseases such as cancer as we are already seeing with gene and cell circuitry technology.


Silicon Valley thrives on disrupting the traditional ways we do many things: education, consuming music and other media, communicate with others, even how we stay healthy. Bill Gates and Dr. Patrick Soon-Shiong know a few things about how to spend a lot of money to disrupt mainstream research while searching for cures in medicine.

Sean Parker hopes to join their ranks. In 1999, he co-founded the file-sharing service Napster, and in 2004, he became the first president of Facebook. Today, Parker announced his latest endeavor: a $250 million bet on eradicating cancer. Through the Parker Institute for Cancer Immunotherapy, he says his plan is just a matter of time until it works.

Continue reading “Can Silicon Valley cure cancer? Napster founder Sean Parker says yes” »